has been cited by the following article(s):
|
[1]
|
CDA formulations to fulfill cancer moonshot and to win the war on cancer
|
|
Int J Res Oncol,
2023 |
|
|
|
|
[2]
|
Newly diagnosed Anaplastic Astrocytoma:> 23 Year Survival in a 31-Year and 11-Month-Old Female Treated with Antineoplastons
|
|
Neurology and …,
2023 |
|
|
|
|
[3]
|
Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with> 35 Years Overall Survival Following Treatment with Antineoplastons
|
|
European Journal of …,
2023 |
|
|
|
|
[4]
|
Recurrent Medulloblastoma: Complete Response and> than 21 Years and Five Months Overall Survival in a One-Year and Seven-Month-Old Male Treated …
|
|
… Review & Reports,
2023 |
|
|
|
|
[5]
|
Newly diagnosed Glioblastoma: Partial Response and> 27 Years Overall Survival in a 37-Year-Old Male Treated with Antineoplastons
|
|
Recent Adv Clin …,
2022 |
|
|
|
|
[6]
|
Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1
|
|
Neurology and …,
2022 |
|
|
|
|
[7]
|
A 25-year-female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with Antineoplastons
|
|
Cancer …,
2022 |
|
|
|
|
[8]
|
Cell Differentiation Agent Formulations to Win the War on Cancer
|
|
Cancer Sci Res,
2022 |
|
|
|
|
[9]
|
Winning Formulas to Fulfill Cancer Moonshot
|
|
Int J Res Oncol,
2022 |
|
|
|
|
[10]
|
Newly-Diagnosed Multicentric Pilocytic Astrocytoma: Complete Response and > 27 Years Survival in a Six Year and Nine-Month-Old Female Treated with Antineoplastons
|
|
International Journal of Clinical Oncology and Cancer Research,
2022 |
|
|
|
|
[11]
|
Long-term survival (23 years) in a 26-year-old male after Antineoplaston therapy for a progressive, diffuse intrinsic pontine glioma: A case report
|
|
Int J Brain Disord …,
2021 |
|
|
|
|
[12]
|
Resolution of clinical signs, a complete response, and long-term survival (> 23 Years) in a 3 and ½ month female with a newly diagnosed diffuse intrinsic …
|
|
Biomed Res,
2021 |
|
|
|
|
[13]
|
Diffuse Intrinsic Pontine Glioma in an 11-Year-Old Female Treated with Antineoplastons: Complete Response and> 25 Years Survival
|
|
Pediatrics and …,
2021 |
|
|
|
|
[14]
|
Development of Synthetic Cell Differentiation Agent Formulations for the Prevention and Therapy of Cancer via Targeting of Cancer Stem Cells
|
|
Cancer Studies and Therapeutics,
2019 |
|
|
|
|
[15]
|
Destabilization of Abnormal Methylation Enzymes: Nature's Way to Eradicate Cancer Stem Cells. On J Complement & Alt Med. 2 (5): 2019
|
|
2019 |
|
|
|
|
[16]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
|
|
Journal of Cancer Therapy,
2015 |
|
|
|
|
[1]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.64036
|
|
|
|